Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Leczna – page 48

865 clinical trials in Leczna, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Leczna at a glance
865
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

865 trials in Leczna

Open in trial search

A Study of Mevrometostat and Enzalutamide for Men with Metastatic Castration-Sensitive Prostate Cancer Who Have Not Received Hormonal Therapy or Chemotherapy

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Enzalutamide
  • Sponsor:Pfizer Inc.

Obesity+1

Not recruiting

A study testing maridebart cafraglutide for weight loss in adults with overweight or obesity, with or without type 2 diabetes

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Breast cancer+3

Not recruiting

Study of romiplostim for treating low platelet counts caused by chemotherapy in adults with non-small cell lung cancer, ovarian cancer, or breast cancer

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Romiplostim
  • Sponsor:Amgen Inc.

Migraine

Not recruiting

Study of Erenumab Compared to Placebo for Children and Adolescents with Episodic Migraine to Reduce Monthly Migraine Days

Investigational
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Erenumab
  • Sponsor:Amgen Inc.

Migraine

Not recruiting

A Study of Erenumab Compared to Placebo for Children and Teenagers With Chronic Migraine to Test How Well It Works and How Safe It Is

Investigational
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Erenumab
  • Sponsor:Amgen Inc.

A study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

A study testing tozorakimab for long-term treatment of chronic obstructive pulmonary disease in former smokers with repeated flare-ups

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:AstraZeneca AB

Major depression

Not recruiting

Testing Ulotaront Added to Antidepressants for Adults with Major Depressive Disorder Who Did Not Respond Well to Initial Treatment

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Citalopram
  • Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.

Dermatomyositis

Not recruiting

A study testing brepocitinib compared to placebo for adults with dermatomyositis to see if it works and is safe

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Brepocitinib Tosilate
  • Sponsor:Priovant Therapeutics Inc.

A study comparing weekly insulin icodec and semaglutide with daily insulin degludec and insulin aspart in people with type 2 diabetes not well controlled on premixed insulin

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Insulin Aspart
  • Sponsor:Novo Nordisk A/S

Endometriosis

Not recruiting

A study testing vipoglanstat for women with moderate to severe endometriosis-related pain

Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Vipoglanstat
  • Sponsor:Gesynta Pharma AB

A study to test how well empagliflozin works and how safe it is for children and teenagers with chronic kidney disease

Registered drug
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Empagliflozin
  • Sponsor:Boehringer Ingelheim Espana S.A.

Other cities in Poland

The busiest research cities in the country

All 236 cities in Poland

Clinical research in Leczna

What the registry says about research in the country

01 Infectious Disease Prevention

Studies focusing on preventive vaccines and treatments for various infectious diseases, including research on meningococcal and pneumococcal vaccines for infants and toddlers, plus investigations into respiratory syncytial virus (RSV) prevention.

  • Meningococcal ACYW conjugate vaccine trials
  • Pneumococcal vaccine safety studies
  • RSV prevention research

Emphasis on immunogenicity and safety profiles in pediatric populations.

02 Gastrointestinal Disorders

Comprehensive research into inflammatory bowel conditions, with multiple trials examining new treatments for Crohn's disease and ulcerative colitis. Studies include novel therapeutic approaches and treatment targets.

  • Obefazimod efficacy studies
  • TEV-48574 clinical evaluation
  • Celiac disease symptom management

Focus on achieving both clinical and endoscopic remission in patients.

03 Critical Care Medicine

Investigations into treatments for severe conditions, including viral lung infections and acute bleeding management. Studies evaluate innovative therapies and emergency interventions.

  • Tozorakimab for respiratory support
  • Anticoagulation reversal studies
  • Burn treatment innovations

Research aimed at improving patient outcomes in urgent care situations.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.